🚀 VC round data is live in beta, check it out!
Phreesia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Phreesia and similar public comparables like Craneware, Guiyang Longmaster, Yidu Tech, RaySearch Labs and more.
Phreesia Overview
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Founded
2005
HQ
Employees
2.1K
Website
Financials (LTM)
EV
$644M
Phreesia Financials
Phreesia reported last 12-month revenue of $492M and EBITDA of $105M.
In the same LTM period, Phreesia generated $402M in gross profit, $105M in EBITDA, and $7M in net income.
Revenue (LTM)
Phreesia P&L
In the most recent fiscal year, Phreesia reported revenue of $420M and EBITDA of $37M.
Phreesia expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $492M | XXX | $420M | XXX | XXX | XXX |
| Gross Profit | $402M | XXX | $285M | XXX | XXX | XXX |
| Gross Margin | 82% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $105M | XXX | $37M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 9% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | (14%) | XXX | XXX | XXX |
| Net Profit | $7M | XXX | ($59M) | XXX | XXX | XXX |
| Net Margin | 1% | XXX | (14%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Phreesia Stock Performance
Phreesia has current market cap of $740M, and enterprise value of $644M.
Market Cap Evolution
Phreesia's stock price is $12.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $644M | $740M | 0.0% | XXX | XXX | XXX | $-0.97 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPhreesia Valuation Multiples
Phreesia trades at 1.3x EV/Revenue multiple, and 6.1x EV/EBITDA.
EV / Revenue (LTM)
Phreesia Financial Valuation Multiples
As of March 31, 2026, Phreesia has market cap of $740M and EV of $644M.
Equity research analysts estimate Phreesia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Phreesia has a P/E ratio of 106.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $740M | XXX | $740M | XXX | XXX | XXX |
| EV (current) | $644M | XXX | $644M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.1x | XXX | 17.5x | XXX | XXX | XXX |
| EV/EBIT | 80.4x | XXX | (11.1x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | 2.3x | XXX | XXX | XXX |
| P/E | 106.8x | XXX | (12.6x) | XXX | XXX | XXX |
| EV/FCF | 11.1x | XXX | 72.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Phreesia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Phreesia Margins & Growth Rates
Phreesia's revenue in the last 12 month grew by 14%.
Phreesia's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Phreesia's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Phreesia's rule of X is 61% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Phreesia Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 27% | XXX | 172% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 61% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 11% | XXX | 18% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 22% | XXX | 28% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 82% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Phreesia Public Comps
See public comps and valuation multiples for other Healthcare Software and EHR & Practice Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Craneware | XXX | XXX | XXX | XXX | XXX | XXX |
| Guiyang Longmaster | XXX | XXX | XXX | XXX | XXX | XXX |
| Yidu Tech | XXX | XXX | XXX | XXX | XXX | XXX |
| RaySearch Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| MedicalSystem Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Phreesia M&A Activity
Phreesia acquired XXX companies to date.
Last acquisition by Phreesia was on XXXXXXXX, XXXXX. Phreesia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Phreesia
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPhreesia Investment Activity
Phreesia invested in XXX companies to date.
Phreesia made its latest investment on XXXXXXXX, XXXXX. Phreesia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Phreesia
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Phreesia
| When was Phreesia founded? | Phreesia was founded in 2005. |
| Where is Phreesia headquartered? | Phreesia is headquartered in United States. |
| How many employees does Phreesia have? | As of today, Phreesia has over 2K employees. |
| Who is the CEO of Phreesia? | Phreesia's CEO is Chaim Indig. |
| Is Phreesia publicly listed? | Yes, Phreesia is a public company listed on NYSE. |
| What is the stock symbol of Phreesia? | Phreesia trades under PHR ticker. |
| When did Phreesia go public? | Phreesia went public in 2019. |
| Who are competitors of Phreesia? | Phreesia main competitors are Craneware, Guiyang Longmaster, Yidu Tech, RaySearch Labs. |
| What is the current market cap of Phreesia? | Phreesia's current market cap is $740M. |
| What is the current revenue of Phreesia? | Phreesia's last 12 months revenue is $492M. |
| What is the current revenue growth of Phreesia? | Phreesia revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Phreesia? | Current revenue multiple of Phreesia is 1.3x. |
| Is Phreesia profitable? | Yes, Phreesia is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Phreesia? | Phreesia's last 12 months EBITDA is $105M. |
| What is Phreesia's EBITDA margin? | Phreesia's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Phreesia? | Current EBITDA multiple of Phreesia is 6.1x. |
| What is the current FCF of Phreesia? | Phreesia's last 12 months FCF is $58M. |
| What is Phreesia's FCF margin? | Phreesia's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Phreesia? | Current FCF multiple of Phreesia is 11.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.